We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.15B
1-Year Est. Return 20.86%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+20.86%
3 Year Est. Return
+68%
5 Year Est. Return
+82.09%
10 Year Est. Return
+321.81%
AUM
$613M
AUM Growth
+$21.7M
Cap. Flow
-$3.21M
Cap. Flow %
-0.52%
Top 10 Hldgs %
22.48%
Holding
251
New
18
Increased
52
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.1M
2
LLY icon
Eli Lilly
LLY
+$3.04M
3
INGR icon
Ingredion
INGR
+$2.73M
4
CSCO icon
Cisco
CSCO
+$2.62M
5
TDW icon
Tidewater
TDW
+$2.35M

Top Sells

Rank Stock Value
1
CF icon
CF Industries
CF
+$4.8M
2
HII icon
Huntington Ingalls Industries
HII
+$3.97M
3
WY icon
Weyerhaeuser
WY
+$3.94M
4
OMC icon
Omnicom Group
OMC
+$3.72M
5
CTRA
Coterra Energy
CTRA
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 12.05%
2 Financials 10.79%
3 Industrials 9.01%
4 Consumer Staples 8.86%
5 Technology 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
26
ExxonMobil
XOM
$651B
$5.84M 0.95%
58,043
+2,551
+5% +$257K
STI
27
DELISTED
SunTrust Banks, Inc.
STI
$5.65M 0.92%
141,006
+20,019
+17% +$780K
AAPL icon
28
Apple
AAPL
$4.89T
$5.6M 0.91%
241,208
-8,580
-3% -$183K
BA icon
29
Boeing
BA
$165B
$5.57M 0.91%
43,789
+2,510
+6% +$328K
EW icon
30
Edwards Lifesciences
EW
$47.6B
$5.55M 0.9%
387,786
+148,290
+62% +$2.01M
PFE icon
31
Pfizer
PFE
$140B
$5.52M 0.9%
195,874
-68,630
-26% -$1.96M
DEO icon
32
Diageo
DEO
$46.2B
$5.5M 0.9%
43,183
-10
-0% -$1.26K
C icon
33
Citigroup
C
$222B
$5.41M 0.88%
114,848
-6,237
-5% -$297K
MAS icon
34
Masco
MAS
$16B
$5.29M 0.86%
271,413
+40,877
+18% +$771K
CVX icon
35
Chevron
CVX
$388B
$5.22M 0.85%
40,020
+242
+0.6% +$30.1K
SLB icon
36
SLB Ltd
SLB
$77.8B
$5.17M 0.84%
43,807
+156
+0.4% +$16.1K
CVS icon
37
CVS Health
CVS
$137B
$4.84M 0.79%
64,218
-1,170
-2% -$88.4K
MKL icon
38
Markel Group
MKL
$25B
$4.67M 0.76%
7,126
+504
+8% +$318K
WFC icon
39
Wells Fargo
WFC
$261B
$4.58M 0.75%
87,239
-1,594
-2% -$80.1K
MLM icon
40
Martin Marietta Materials
MLM
$33.6B
$4.58M 0.75%
34,715
+4,030
+13% +$506K
GILD icon
41
Gilead Sciences
GILD
$161B
$4.36M 0.71%
+52,627
New +$4.1M
PEP icon
42
PepsiCo
PEP
$186B
$4.35M 0.71%
48,648
-197
-0.4% -$17K
MRK icon
43
Merck
MRK
$324B
$4.14M 0.67%
74,946
-83
-0.1% -$4.53K
CXT icon
44
Crane NXT
CXT
$3.04B
$4.12M 0.67%
159,353
-4,606
-3% -$116K
FISV
45
Fiserv Inc
FISV
$27.2B
$3.98M 0.65%
131,852
– –
ESL
46
DELISTED
Esterline Technologies
ESL
$3.93M 0.64%
34,150
+3,365
+11% +$371K
WTW icon
47
Willis Towers Watson
WTW
$27.9B
$3.89M 0.63%
33,918
-1,831
-5% -$206K
VEA icon
48
Vanguard FTSE Developed Markets ETF
VEA
$226B
$3.81M 0.62%
89,420
-21,030
-19% -$886K
NVS icon
49
Novartis
NVS
$295B
$3.77M 0.61%
46,464
-2,153
-4% -$169K
WMT icon
50
Walmart Inc
WMT
$871B
$3.76M 0.61%
150,156
-2,925
-2% -$75.1K
1
2
3 4 5

Similar funds

IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return

Montag & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Montag & Associates held 251 positions worth $613M, up 3.7% from $592M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Montag & Associates's Q2 2014 filing shows 18 new, 52 increased, 87 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 52,627 shares worth $4.36M. The largest sale was CF Industries, an estimated $4.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Montag & Associates's largest Q2 2014 buy was Gilead Sciences: 52,627 shares worth $4.36M.
  • Montag & Associates added most to Eli Lilly in Q2 2014, an estimated $3.04M increase.
  • Montag & Associates's biggest Q2 2014 reduction was Huntington Ingalls Industries, cutting an estimated $3.97M.
  • Montag & Associates fully exited CF Industries in Q2 2014, selling an estimated $4.8M.
  • Montag & Associates's ten largest holdings make up 22% of its $613M portfolio in Q2 2014.
  • Montag & Associates opened 18 new positions and closed 9 in Q2 2014.
  • Montag & Associates's portfolio value rose 3.7% quarter-over-quarter to $613M.

Based on Montag & Associates's 13F filing for Q2 2014, filed 6 Aug 2014.